Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: A case report and review of the literature

Gynecologic and Obstetric Investigation

Volumn 77, Issue 1, 2014, Pages 1-5

  Petrillo, M ^a   Legge, F ^b   Ferrandina, G ^a   Monterisi, A ^a   Pedone Anchora, L ^a   Scambia, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Favorable histology; Fertility sparing surgery; Oncological and obstetric outcome; Ovarian cancer; Stage II III disease

Indexed keywords

CARBOPLATIN; DOXORUBICIN;

ADULT; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CASE REPORT; CONSERVATIVE TREATMENT; DRUG WITHDRAWAL; FEMALE; FERTILITY SPARING SURGERY; HUMAN; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; TRANSVAGINAL ECHOGRAPHY; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL FEATURE; ENDOMETRIOID CARCINOMA; OVARY CANCER; SURGICAL TECHNIQUE;

ADULT; CARCINOMA, ENDOMETRIOID; FEMALE; FERTILITY PRESERVATION; HISTOCYTOCHEMISTRY; HUMANS; INFANT, NEWBORN; LAPAROTOMY; OVARIAN NEOPLASMS; PREGNANCY;

EID: 84896722886     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000353277     Document Type: Review

References (13)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al: Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95(suppl 1):S161-S192.
3. Colombo N, Parma G, Lapresa MT, Maggi F, Piantanida P, Maggioni A: Role of conservative surgery in ovarian cancer: the European experience. Int J Gynecol Cancer 2005; 15(suppl 3):206-211.
4. Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE: Fertilitypreserving options in patients with gynecologic malignancies. Am J Obstet Gynecol 2011; 205: 103-110.
5. Morice P, Wicart-Poque F, Rey A, El-Hassan J, Pautier P, Lhommé C, de Crevosier R, et al: Results of conservative treatment in epithelial ovarian carcinoma. Cancer 2001; 92: 2412-2418.
6. Morice P, Leblanc E, Rey A, Baron M, Querleu D, Blanchot J, et al: Conservative treatment in epithelial ovarian cancer: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Française d'Oncologie Gynécologique). Hum Reprod 2005; 20: 1379-1385.
7. Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, et al: Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol 2008; 110: 345-353.
8. Fruscio R, Corso S, Ceppi L, Garavaglia D, Garbi A, Floriani I, et al: Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol 2013; 24: 138-144.
9. Duska LR, Chang YC, Flynn CE, Chen AH, Goodman A, Fuller AF, et al: Epithelial ovarian carcinoma in the reproductive age group. Cancer 1999; 85: 2623-2629.
10. Raspagliesi F, Fontanelli R, Paladini D, di Re EM: Conservative surgery in high-risk epithelial ovarian carcinoma. J Am Coll Surg 1997; 185: 457-460.
11. Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Nawa A, et al: Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. Br J Cancer 2011; 105: 1288-1294.
12. Benjamin I, Morgan MA, Rubin SC: Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol 1999; 72: 288-291.
13. Munnell EW: Is conservative therapy ever justified in stage I (IA) cancer of the ovary? Am J Obstet Gynecol 1969; 103: 641-653.